The studies performed on NK cells in cancers showed that INF-γ can induce IDO1 mRNA expression in NK cells, and pharmacological inhibition of the enzyme may reduce cytotoxicity against cancer cells both in in vitro [129] and in vivo conditions [99]. The gene discussed is IDO1; the disease is cancer.